Study guide
17.4 Genetics, Genomics & Pharmacogenomics
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
17.4 Genetics, Genomics & Pharmacogenomics
Key Takeaways Explain This Topic AI
Autosomal dominant conditions give each child of an affected parent a 50% risk; autosomal recessive conditions give a 25% risk to each child of two carriers.
In X-linked recessive conditions such as haemophilia and Duchenne muscular dystrophy, there is no male-to-male transmission and all daughters of an affected man are carriers.
Lynch syndrome is a mismatch repair gene condition that greatly increases the risk of colorectal and endometrial cancer; NICE recommends testing all such tumours for it.
HLA-B 5801 predicts severe skin reactions to allopurinol, HLA-B 1502 to carbamazepine and HLA-B*5701 to abacavir, while DPYD variants predict fluoropyrimidine toxicity.
CYP2D6 ultra-rapid metabolisers convert codeine to morphine quickly, causing toxicity; codeine is contraindicated in breastfeeding and in children under 12.
Last updated: October 2026
- Genetics, Genomics & Pharmacogenomics
- Patterns of Inheritance
Pattern Key Features Examples
Autosomal dominant Affected people in every generation ; males and females equally affected; 50% risk to each child of an affected parent; variable expressivity and incomplete penetrance Huntington's disease, familial hypercholesterolaemia , adult polycystic kidney disease, Marfan syndrome , neurofibromatosis type 1, hypertrophic cardiomyopathy, BRCA1/2 , Lynch syndrome, myotonic dystrophy
Autosomal recessive Parents usually unaffected carriers ; 25% risk of an affected child when both parents carry the variant (50% carriers); more common with consanguinity Cystic fibrosis, sickle cell disease, thalassaemia , haemochromatosis, phenylketonuria, Wilson's disease, spinal muscular atrophy
X-linked recessive Mainly males affected; no male-to-male transmission ; sons of carrier women have a 50% risk; all daughters of an affected man are carriers Haemophilia A and B , Duchenne and Becker muscular dystrophy , G6PD deficiency , red-green colour blindness
X-linked dominant Affected fathers pass it to all daughters and no sons X-linked hypophosphataemic rickets
Mitochondrial Maternal inheritance only; variable severity (heteroplasmy) MELAS, Leber's hereditary optic neuropathy
Trinucleotide Repeat Disorders & Anticipation
Expanding repeats cause anticipation (earlier onset or greater severity in successive generations): Huntington's disease (CAG; worse with paternal transmission), myotonic dystrophy (CTG; congenital form via the mother), fragile X syndrome (CGG; the commonest inherited cause of learning disability) and Friedreich's ataxia (GAA).
Chromosomal Disorders
Condition Karyotype Key Features
Down's syndrome Trisomy 21 (mostly non-disjunction, linked to maternal age; about 4% Robertsonian translocation, which can be inherited) Learning disability, hypotonia, flat facial profile, single palmar crease; atrioventricular septal defect , duodenal atresia , hypothyroidism, coeliac disease, leukaemia, early-onset Alzheimer's disease
Edwards' syndrome Trisomy 18 Rocker-bottom feet, clenched hands with overlapping fingers, cardiac defects; most die in infancy
Patau's syndrome Trisomy 13 Midline defects (cleft lip and palate, holoprosencephaly), polydactyly; most die in infancy
Turner syndrome 45,X Short stature , webbed neck, coarctation and bicuspid aortic valve , primary amenorrhoea (streak ovaries), lymphoedema in newborns
Klinefelter syndrome 47,XXY Tall, small firm testes, infertility , gynaecomastia, hypogonadism
22q11.2 deletion (DiGeorge) syndrome Microdeletion Cardiac defects (tetralogy of Fallot), cleft palate, hypocalcaemia (absent parathyroids), immunodeficiency (thymic hypoplasia), learning and psychiatric difficulties
Hereditary Cancer & Other Common Genetic Conditions
BRCA1/BRCA2: high risks of breast and ovarian cancer (and prostate and pancreatic cancer with BRCA2). Carriers are offered enhanced breast surveillance, risk-reducing mastectomy or salpingo-oophorectomy, and cascade testing of relatives.
Lynch syndrome: an autosomal dominant mismatch repair gene variant causing early colorectal and endometrial cancers (and others). NICE recommends testing all colorectal and endometrial cancers for mismatch repair deficiency to find families with Lynch syndrome, who then have colonoscopic surveillance and aspirin may be considered.
Familial adenomatous polyposis (APC gene): hundreds of colonic polyps from adolescence and near-certain colorectal cancer without prophylactic colectomy .
Familial hypercholesterolaemia (NICE CG71): suspect with a total cholesterol above 7.5 mmol/L in adults or a personal or family history of premature coronary heart disease; use the Simon Broome or Dutch Lipid Clinic criteria, offer high-intensity statins , and arrange cascade testing of relatives (including children).
Hereditary haemochromatosis (HFE C282Y homozygosity): fatigue, arthralgia, raised transferrin saturation and ferritin , diabetes, liver disease and skin pigmentation; treated with venesection .
Genomic Medicine in the NHS
The NHS Genomic Medicine Service (from 2018) provides testing through regional laboratory hubs according to the National Genomic Test Directory , including whole genome sequencing for some rare diseases and cancers. Results may be diagnostic (explaining a condition), predictive (risk of future disease), carrier results, or incidental (secondary) findings .
Pharmacogenomics
- Gene / Marker Drug Consequence
- HLA-B*5801 Allopurinol Severe cutaneous adverse reactions (common in Han Chinese, Korean, Thai ancestry)
- HLA-B*1502 Carbamazepine Stevens-Johnson syndrome or TEN (Han Chinese, Thai ancestry): test before starting
- HLA-B*5701 Abacavir Hypersensitivity reaction: test before starting
TPMT / NUDT15 Azathioprine, mercaptopurine Severe bone marrow suppression with low activity: check before starting
DPYD Fluorouracil, capecitabine Severe or fatal toxicity: test before chemotherapy
CYP2C19 Clopidogrel Poor metabolisers gain less antiplatelet effect; NICE recommends genotype testing to guide treatment after ischaemic stroke or TIA
CYP2D6 Codeine , tramadol Ultra-rapid metabolisers form morphine quickly (toxicity); codeine is contraindicated in breastfeeding and in children under 12
MT-RNR1 Aminoglycosides (gentamicin) Permanent hearing loss after a single dose; rapid testing is used in some neonatal units
Ethics of Genetic Testing
Pre-test counselling and consent: discuss the purpose, possible results (including uncertain variants and incidental findings), and implications for relatives , insurance and mental health.
Predictive testing for adult-onset conditions (for example Huntington's disease) is usually deferred in children until they can decide for themselves, unless results change childhood care.
Confidentiality and relatives: genetic information is also relevant to family members. Encourage patients to share results; GMC guidance allows disclosure without consent in exceptional cases where the risk to a relative is serious and could be reduced, after weighing the patient's interests (the duty to consider this was confirmed in ABC v St George's Healthcare , 2020).
Insurance: the UK Code on Genetic Testing and Insurance means people are not required to disclose predictive genetic test results for most insurance (except Huntington's disease for large life insurance policies).
Loading diagram...